Research
The primary goal of the international COVID-19 Technology Access Pool (C-TAP) to facilitate access to COVID-19 health products received a major boost last week with an offer from the U.S. National Institutes of Health (NIH) for several related technologies.
These offers would allow potential... Read More »
The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) recently released a Request for Information (RFI) to obtain first responder new and emerging technologies.
First responders would experiment with and test the technological offerings during the multi-day... Read More »
Global aerospace company Boeing is detailing the construction of the latest Wideband Global SATCOM (WGS) satellite system version, highlighting advanced techniques effectively integrating commercial technology.
"We're moving at record-breaking speed to deliver the unmatched resilience,... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) will continue long-standing partnerships with GlaxoSmithKline (GSK), Sanofi, and Seqirus to build up medical countermeasures to influenza pandemics and other public health emergencies.
For years, these partnerships and other... Read More »
With test data showing their COVID-19 vaccine’s capabilities to fight COVI-19 in regular or booster form, Sanofi and GSK announced this week that they intend to submit data as the foundation of regulatory authorization requests.
The Sanofi-GSK offering is a refrigerator temperature-stable,... Read More »
Nuclear Threat Initiative (NTI) and Munich Security Conference (MSC) personnel are espousing the benefits of a recently convened tabletop exercise to reduce high-consequence biological threats.
The effort involved uniting senior leaders from across government, industry, and civil society to... Read More »
Following an endorsement from the independent Data and Safety Monitoring Board this week, Moderna, Inc. officially began the third phase of trials for its mRNA Respiratory Syncytial Virus (RSC) vaccine candidate this week.
The safety greenlight was based on preliminary Phase 2 safety and... Read More »
A virtual event organized by the Coalition for Epidemic Preparedness Innovations (CEPI), the Johns Hopkins Center for Health Security, and the German Federal Ministry of Education and Research last week pulled in government officials and technical experts to address the best means of accelerating... Read More »
The ReVector program – an anti-mosquito Defense Advanced Research Projects Agency (DARPA) creation undertaken at Stanford University – entered its next research phase this month, advancing to animal testing.
“Phase 1 of the program focused on identifying microbial or metabolic targets... Read More »
A group of Republican legislators recently forwarded correspondence to President Joe Biden, seeking clarity on re-imposing limits on ground-based missiles in Europe and the Indo-Pacific.
U.S. Reps. Mike Gallagher (R-WI), Mike Rogers (R-AL), Michael McCaul (R-TX), Michael Turner (R-OH), Elise... Read More »
The National Institutes of Health (NIH) last week announced the allocation of $4.5 million across three grant awards to create collaborative research centers in the United States, focusing specifically on investigating treatments and vaccines specifically related to Valley Fever.
These centers... Read More »
Years into a global pandemic, the Access to COVID-19 Tools (ACT) Accelerator and affiliated world leaders have called for fair, shared-based financing of approximately $23 billion in 2022 to overcome inequalities in medical access, scale-up countermeasure efforts, and end the COVID-19... Read More »
The U.S. Department of Homeland Security (DHS) Small Business Innovation Research (SBIR) Program is seeking information regarding building collapse search and rescue technologies.
The DHS Science and Technology Directorate (S&T) administered SBIR Program has issued an Other Agency Technology... Read More »
Phase 2 testing of a Lyme disease vaccine candidate, VLA15, produced strong immune responses, according to the newest data from Valneva SE and Pfizer inc, prompting preparations for a Phase 3 study in the third quarter of 2022.
The VLA15-221 trial produced stronger responses in adult... Read More »
The Office of Justice Programs’ (OJP) National Institute of Justice (NIJ) has released study findings regarding traits of persons who engaged in mass shootings between 1966 and 2019.
“This study — one of the most extensive assessments of mass violence to date—reveals a deeply unsettling... Read More »
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) released a new Pandemic Preparedness Plan this week, directing its research efforts toward identifying pathogens with potential for significant spread among humans and those already known to be major threats.
Informed by a... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) awarded more than $4.5 million in total awards this week to support research into valley fever being conducted by the Universities of California-San Francisco, California-Los Angeles, and Texas-San Antonio.
That money will be... Read More »
The University of Maryland (UMD) has secured a Department of Defense (DOD) award totaling nearly $4 million to support data collection efforts on terrorism-related projects and other asymmetric threats.
The DOD would fund data collection on several projects that include the Study of Terrorism... Read More »
Citing data from six preclinical studies, Merck and Ridgeback Biotherapeutics last week announced that their oral antiviral COVID-19 medicine, molnupiravir, maintained efficacy against the widespread Omicron variant.
These in vitro lab studies were independently organized and conducted by... Read More »
In a letter written to the U.S. Office of Science and Technology Policy (OSTP) and the National Science Foundation (NSF), a bipartisan collection of senators and representatives last week urged continued pursuit of artificial intelligence development, albeit with special care to ethics and... Read More »
In a letter dispatched to Army Secretary Christine Wormuth last week, U.S. Senate Majority Leader Charles Schumer, U.S. Sen. Kirsten Gillibrand, along with U.S. Reps Brian Higgins and Joseph Morelle, urged the development of new cameras to boost military situational awareness.
Specifically, they... Read More »
Results of a multinational, Phase 3 National Institute of Allergy and Infectious Diseases (NIAID)-funded trial last week showed that combining remdesivir with anti-coronavirus hyperimmune intravenous immunoglobulin (HIVIG) fails to do more for COVID-19 hospitalized adults than remdesivir... Read More »
Moderna, Inc. dosed the first participant this week for its Phase 2 study of a COVID-19 booster vaccine tailored to the omicron variant, mRNA-1273.529, kicking off a two cohort trial that will span the United States.
In all, approximately 300 participants will be enrolled in each cohort. One... Read More »
Drawing from a $200 million program meant to stimulate the development of vaccines with broad betacoronavirus protection, the Coalition for Epidemic Preparedness Innovations (CEPI) announced a $16.9 million award this week for development efforts by BioNet.
BioNet, a French-Thai vaccine... Read More »
The U.S. Customs and Border Protection (CBP) issued Monday its December 2021 operational statistics update, which offers a comprehensive view of agency initiatives.
“The dedicated men and women at CBP are committed to ensuring dangerous drugs and counterfeit products are off the streets, our... Read More »
In support of the federal Project BioShield incentivization effort, the Biomedical Advanced Research and Development Authority (BARDA) recently launched a Request for Proposals for late-stage development, approval, and procurement of an antibiotic capable of overcoming... Read More »
The Coalition for Epidemic Preparedness Innovations’ (CEPI) 100 Days Mission to reduce the vaccine development timeline received a $300 million investment from the Bill & Melinda Gates Foundation and Wellcome.
While a fraction of the organization’s overall fundraising goal of $3.5 billion,... Read More »
A Transportation Security Administration (TSA) report determined firearm discoveries at Georgia airports increased in 2021.
Per the analysis, officers at Georgia airports discovered 542 firearms in travelers’ carry-on luggage last year, with Hartsfield-Jackson Atlanta International Airport... Read More »
Under a long-term agreement with the United Nations Children’s Fund (UNICEF) announced this week, Merck and Ridgeback Biotherapeutics have agreed to provide 3 million courses of COVID-19 oral antiviral molnupiravir for use in low and middle-income countries.
Distribution will occur throughout... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) and Institut Pasteur de Dakar (IPD) recently collaborated to advance COVID-19 vaccine manufacturing in Africa.
CEPI seeks to develop vaccines against future epidemics, while IPD is a non-profit public interest foundation located in... Read More »
A new partnership between governmental, military, and academic scientists seeks to collaboratively develop a vaccine over the next five years capable of protecting against tularemia, melioidosis, and plague from a single source.
Aided by a $10 million grant for the Defense Threat Reduction... Read More »
Defense Advanced Research Projects Agency (DARPA) officials said the agency has selected 10 industry and university research teams for the Enhanced Night Vision in Eyeglass Form (ENVision) program.
Authorities indicated ENVision's goal is to leverage recent advances in night vision (NV) systems... Read More »
Expanding options for individuals with COVID-19, the World Health Organization (WHO) last week recommended two additional drugs for treatment: the oral inhibitor known as baricitinib and the monoclonal antibody drug sotrovimab.
Baricitinib is meant for use by those with severe or critical... Read More »
While Cue Health already has a COVID-19 test on the market capable of detecting the widespread omicron variant, the organization announced that it will work with the Biomedical Advanced Research and Development Authority (BARDA) to create a point-of-care test specifically focused on rooting out... Read More »
Lockheed Martin officials are detailing the F-35 fighter jet program's progression, noting the continued expansion of its global footprint and operational capabilities enhancement.
"The F-35 joint enterprise team continues to provide unmatched combat capability to the 21st-century battlespace... Read More »
